An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized Trial
Anthony Cahn(GlaxoSmithKline (United Kingdom)), Edith M. Hessel(Eligo Bioscience (France)), Wim Vos(Fluidda (Belgium)), Cedric Van Holsbeke(Fluidda (Belgium)), Yi Cui(Kunming University of Science and Technology), Gordon J. Dear, Claudia Leemereise(Discovery Centre), Emily Jarvis(Age UK), Robert C. Wilson(Georgia Institute of Technology), Malcolm Begg(Discovery Centre), Mickaël Montembault(Discovery Centre), Wilfried De Backer(University of Antwerp), Jan De Backer(Fluidda (Belgium)), J. Hamblin(GlaxoSmithKline (United Kingdom)), Jon Robertson(Discovery Centre), Maki Mizuma(GlaxoSmithKline (Japan))
Cited by 18
Related Papers
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung Cancer
|JAMA Oncology|2017|603
Martensitic transformation and shape memory effect in ferromagnetic Heusler alloy Ni2FeGa
|Applied Physics Letters|2003|272
The Immune Subtypes and Landscape of Squamous Cell Carcinoma
|Clinical Cancer Research|2019|206
Intratumor partitioning and texture analysis of dynamic contrast‐enhanced (DCE)‐MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy
|Journal of Magnetic Resonance Imaging|2016|171
<i>MiR-125b</i> Expression Affects the Proliferation and Apoptosis of Human Glioma Cells by Targeting <i>Bmf</i>
|Cellular Physiology and Biochemistry|2009|153